Cargando…
Characterization of AKT Somatic Mutations in Chinese Breast Cancer Patients
PURPOSE: This study aimed to investigate AKT gene mutation status in Chinese breast cancer patients. METHODS: The study included 411 breast cancer patients hospitalized in Guangdong Provincial People’s Hospital (GDPH) from June 1, 2017 to September 27, 2018. Mastectomy or breast conserving surgery w...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039050/ https://www.ncbi.nlm.nih.gov/pubmed/33854375 http://dx.doi.org/10.2147/CMAR.S299624 |
_version_ | 1783677510183026688 |
---|---|
author | Wen, Lingzhu Zhang, Guochun Ren, Chongyang Li, Xuerui Mok, Hsiaopei Jia, Minghan Wang, Yulei Chen, Bo Li, Kai Cao, Li Li, Cheukfai Xiao, Weikai Lai, Jianguo Lin, Jiali Wei, Guangnan Li, Yingzi Zhang, Yuchen Chen, Xiaoqing Liao, Ning |
author_facet | Wen, Lingzhu Zhang, Guochun Ren, Chongyang Li, Xuerui Mok, Hsiaopei Jia, Minghan Wang, Yulei Chen, Bo Li, Kai Cao, Li Li, Cheukfai Xiao, Weikai Lai, Jianguo Lin, Jiali Wei, Guangnan Li, Yingzi Zhang, Yuchen Chen, Xiaoqing Liao, Ning |
author_sort | Wen, Lingzhu |
collection | PubMed |
description | PURPOSE: This study aimed to investigate AKT gene mutation status in Chinese breast cancer patients. METHODS: The study included 411 breast cancer patients hospitalized in Guangdong Provincial People’s Hospital (GDPH) from June 1, 2017 to September 27, 2018. Mastectomy or breast conserving surgery was performed, and tissue samples were subjected to next-generation sequencing (NGS) to determine AKT gene mutation status. Meanwhile, the expression of human epidermal growth factor receptor 2 (Her2), progesterone receptor (PR), and estrogen receptor (ER) was analyzed by immunohistochemistry staining. The Cancer Genome Atlas (TCGA) database was used for comparative studies. RESULTS: Patients in the GDPH cohort had an older age (P < 0.001), higher postmenopausal rate (P < 0.001), larger tumor size (P < 0.001), higher histologic type of infiltrating duct cancer (P < 0.001), higher metastatic rate (P < 0.001), higher expression of ER (P = 0.015) and HER2 (P < 0.001), and higher percentage of the HR/HER2 subtype (P < 0.001) than those in the TCGA cohort. The GDPH cohort displayed lower rates of overall AKT and AKT3 mutation (P < 0.001), but a higher AKT1 mutation rate (P < 0.0001) compared with the TCGA cohort. Notably, the NGS studies identified missense mutation and copy number amplification as the most common AKT variation type in the GDPH and TCGA cohorts, respectively. Specifically, E17K mutation in AKT1 was predominantly detected in GDPH cohort, while being absent in TCGA cohort. Moreover, in the GDPH cohort, AKT variation was correlated with a number of clinicopathological variables, including age over 50, HER2-, HR+/HER2-, and PR+. CONCLUSION: Patients in the GDPH cohort had lower rates of AKT and AKT3 mutation and higher AKT1 mutation rate than those in the TCGA cohort, while harboring missense mutations detected predominantly as E17K mutation in AKT1. In GDPH cohort, there were correlations between AKT mutation and the clinicopathological characteristics of patients. |
format | Online Article Text |
id | pubmed-8039050 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-80390502021-04-13 Characterization of AKT Somatic Mutations in Chinese Breast Cancer Patients Wen, Lingzhu Zhang, Guochun Ren, Chongyang Li, Xuerui Mok, Hsiaopei Jia, Minghan Wang, Yulei Chen, Bo Li, Kai Cao, Li Li, Cheukfai Xiao, Weikai Lai, Jianguo Lin, Jiali Wei, Guangnan Li, Yingzi Zhang, Yuchen Chen, Xiaoqing Liao, Ning Cancer Manag Res Original Research PURPOSE: This study aimed to investigate AKT gene mutation status in Chinese breast cancer patients. METHODS: The study included 411 breast cancer patients hospitalized in Guangdong Provincial People’s Hospital (GDPH) from June 1, 2017 to September 27, 2018. Mastectomy or breast conserving surgery was performed, and tissue samples were subjected to next-generation sequencing (NGS) to determine AKT gene mutation status. Meanwhile, the expression of human epidermal growth factor receptor 2 (Her2), progesterone receptor (PR), and estrogen receptor (ER) was analyzed by immunohistochemistry staining. The Cancer Genome Atlas (TCGA) database was used for comparative studies. RESULTS: Patients in the GDPH cohort had an older age (P < 0.001), higher postmenopausal rate (P < 0.001), larger tumor size (P < 0.001), higher histologic type of infiltrating duct cancer (P < 0.001), higher metastatic rate (P < 0.001), higher expression of ER (P = 0.015) and HER2 (P < 0.001), and higher percentage of the HR/HER2 subtype (P < 0.001) than those in the TCGA cohort. The GDPH cohort displayed lower rates of overall AKT and AKT3 mutation (P < 0.001), but a higher AKT1 mutation rate (P < 0.0001) compared with the TCGA cohort. Notably, the NGS studies identified missense mutation and copy number amplification as the most common AKT variation type in the GDPH and TCGA cohorts, respectively. Specifically, E17K mutation in AKT1 was predominantly detected in GDPH cohort, while being absent in TCGA cohort. Moreover, in the GDPH cohort, AKT variation was correlated with a number of clinicopathological variables, including age over 50, HER2-, HR+/HER2-, and PR+. CONCLUSION: Patients in the GDPH cohort had lower rates of AKT and AKT3 mutation and higher AKT1 mutation rate than those in the TCGA cohort, while harboring missense mutations detected predominantly as E17K mutation in AKT1. In GDPH cohort, there were correlations between AKT mutation and the clinicopathological characteristics of patients. Dove 2021-04-07 /pmc/articles/PMC8039050/ /pubmed/33854375 http://dx.doi.org/10.2147/CMAR.S299624 Text en © 2021 Wen et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Wen, Lingzhu Zhang, Guochun Ren, Chongyang Li, Xuerui Mok, Hsiaopei Jia, Minghan Wang, Yulei Chen, Bo Li, Kai Cao, Li Li, Cheukfai Xiao, Weikai Lai, Jianguo Lin, Jiali Wei, Guangnan Li, Yingzi Zhang, Yuchen Chen, Xiaoqing Liao, Ning Characterization of AKT Somatic Mutations in Chinese Breast Cancer Patients |
title | Characterization of AKT Somatic Mutations in Chinese Breast Cancer Patients |
title_full | Characterization of AKT Somatic Mutations in Chinese Breast Cancer Patients |
title_fullStr | Characterization of AKT Somatic Mutations in Chinese Breast Cancer Patients |
title_full_unstemmed | Characterization of AKT Somatic Mutations in Chinese Breast Cancer Patients |
title_short | Characterization of AKT Somatic Mutations in Chinese Breast Cancer Patients |
title_sort | characterization of akt somatic mutations in chinese breast cancer patients |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039050/ https://www.ncbi.nlm.nih.gov/pubmed/33854375 http://dx.doi.org/10.2147/CMAR.S299624 |
work_keys_str_mv | AT wenlingzhu characterizationofaktsomaticmutationsinchinesebreastcancerpatients AT zhangguochun characterizationofaktsomaticmutationsinchinesebreastcancerpatients AT renchongyang characterizationofaktsomaticmutationsinchinesebreastcancerpatients AT lixuerui characterizationofaktsomaticmutationsinchinesebreastcancerpatients AT mokhsiaopei characterizationofaktsomaticmutationsinchinesebreastcancerpatients AT jiaminghan characterizationofaktsomaticmutationsinchinesebreastcancerpatients AT wangyulei characterizationofaktsomaticmutationsinchinesebreastcancerpatients AT chenbo characterizationofaktsomaticmutationsinchinesebreastcancerpatients AT likai characterizationofaktsomaticmutationsinchinesebreastcancerpatients AT caoli characterizationofaktsomaticmutationsinchinesebreastcancerpatients AT licheukfai characterizationofaktsomaticmutationsinchinesebreastcancerpatients AT xiaoweikai characterizationofaktsomaticmutationsinchinesebreastcancerpatients AT laijianguo characterizationofaktsomaticmutationsinchinesebreastcancerpatients AT linjiali characterizationofaktsomaticmutationsinchinesebreastcancerpatients AT weiguangnan characterizationofaktsomaticmutationsinchinesebreastcancerpatients AT liyingzi characterizationofaktsomaticmutationsinchinesebreastcancerpatients AT zhangyuchen characterizationofaktsomaticmutationsinchinesebreastcancerpatients AT chenxiaoqing characterizationofaktsomaticmutationsinchinesebreastcancerpatients AT liaoning characterizationofaktsomaticmutationsinchinesebreastcancerpatients |